LAS CRUCES, N.M.–(BUSINESS WIRE)–Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic” or the “Company”), a vertically integrated aerospace and space travel company, today announced its financial results for the first quarter ended March 31, 2021.

“We continue to make strides towards our strategic objectives and have solid momentum as we focus on completing our flight test program,” said Michael Colglazier, Chief Executive Officer of Virgin Galactic. “We are committed to delivering one of the world’s most unique and transformational customer experiences, with safety at the core of everything we do. Our greatest asset is our incredibly talented group of employees, and the strength of the leadership team we have assembled for the next phase of our journey.”

First Quarter 2021 Business Highlights:

  • Unveiled VSS Imagine, the first SpaceShip III class vehicle in Virgin Galactic’s growing fleet, on March 30, 2021.
  • Total Future Astronauts remained at approximately 600, as of March 31, 2021.
  • Continue to build senior management team:

    • Appointed Doug Ahrens as Chief Financial Officer, effective March 1, 2021.
    • Appointed Swami Iyer as President of Aerospace Systems, effective March 22, 2021.
    • Appointed Stephen Justice as Vice President of Engineering, effective March 1, 2021.
  • Established and launched the Virgin Galactic Space Advisory Board, composed of leading experts from the aerospace sector.
  • Announced a three-year extension to the global Land Rover partnership.

First Quarter 2021 Financial Highlights:

  • Cash position remains strong, with cash and cash equivalents of $617 million as of March 31, 2021.
  • Net loss of $130 million, compared to a $377 million net loss in the first quarter of 2020.
  • GAAP selling, general, and administrative expenses of $45 million, compared to $27 million in the first quarter of 2020. Non-GAAP selling, general and administrative expenses of $27 million in the first quarter of 2021, compared to $23 million in the first quarter of 2020.
  • GAAP research and development expenses of $36 million, compared to $34 million in the first quarter of 2020. Non-GAAP research and development expenses of $32 million in the first quarter of 2020, compared to $33 million in the first quarter of 2020.
  • Adjusted EBITDA totaled $(56) million, compared to $(53) million in the first quarter of 2020.
  • Cash paid for capital expenditures totaled $1 million, compared to $4 million in the first quarter of 2020.

Recent Updates:

  • Completed corrective EMI work on VSS Unity such that the spaceship is ready to start pre-flight procedures for flight
  • Timing of next flight test is currently being evaluated

COVID-19 Impact

The Company is continuing to experience ongoing delays to its business and operations due to COVID-19. The Company continues to operate under strict protocols and follows rigorous health and safety procedures, in line with CDC, state and local guidelines, to ensure employee safety.

Conference Call Information

Virgin Galactic will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) today. To access the conference call, parties should dial (833) 968-2325 and enter the conference ID number 2488377. The live audio webcast along with supplemental information will be accessible on the Company’s Investor Relations website at investors.virgingalactic.com. A recording of the webcast will also be available following the conference call.

About Virgin Galactic Holdings

Virgin Galactic Holdings, Inc. is a vertically integrated aerospace and space travel company, pioneering human spaceflight for private individuals and researchers, as well as a manufacturer of advanced air and space vehicles. The Company is developing a spaceflight system designed to offer customers a unique and transformative experience. You can find more information at https://www.virgingalactic.com.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of federal securities laws with respect to Virgin Galactic Holdings, Inc. (the “Company”), including statements regarding the Company’s spaceflight systems, markets and expected flight schedule. These forward-looking statements generally are identified by words such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the factors, risks and uncertainties included in Amendment No. 2 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.virgingalactic.com. These filings identify and address other important risks and uncertainties that could cause the Company’s actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

First Quarter 2021 Financial Results

 

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited and in thousands except for per share data)

 

 

Three Months Ended

 

 

March 31, 2021

 

March 31, 2020

 

 

 

 

(As restated)

Revenue

 

$

 

 

 

$

238

 

 

Cost of revenue

 

 

 

 

173

 

 

Gross profit

 

 

 

 

65

 

 

Selling, general, and administrative expenses

 

44,914

 

 

 

26,755

 

 

Research and development expenses

 

36,363

 

 

 

34,282

 

 

Operating loss

 

(81,277

)

 

 

(60,972

)

 

Change in fair value of warrants

 

(48,719

)

 

 

(316,896

)

 

Interest income (expense), net

 

318

 

 

 

1,168

 

 

Other income (expense), net

 

27

 

 

 

(172

)

 

Loss before income taxes

 

(129,651

)

 

 

(376,872

)

 

Income tax benefit (expense)

 

(43

)

 

 

46

 

 

Net loss

 

(129,694

)

 

(376,826

)

 

Other comprehensive loss:

 

 

 

 

Foreign currency translation adjustment

 

27

 

 

 

(54

)

 

Total comprehensive loss

 

$

(129,667

)

 

 

$

(376,880

)

 

 

 

 

 

 

 

 

 

 

 

Net loss per share:

 

 

 

 

Basic and diluted

 

$

(0.55

)

 

 

$

(1.86

)

 

 

 

 

 

 

Weighted-average shares outstanding:

Basic and diluted

 

234,191,636

 

 

 

202,409,552

 

 

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Balance Sheets

(In thousands, except share data)

 

 

 

March 31, 2021

 

December 31, 2020

 

 

(Unaudited)

 

(As restated)

Assets

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

$

616,625

 

 

 

$

665,924

 

 

Restricted cash

 

13,031

 

 

 

13,031

 

 

Inventories

 

30,187

 

 

 

30,483

 

 

Prepaid expenses and other current assets

 

14,486

 

 

 

18,489

 

 

Total current assets

 

674,329

 

 

 

727,927

 

 

Property, plant, and equipment, net

 

50,936

 

 

 

53,148

 

 

Other non-current assets

 

22,762

 

 

 

22,915

 

 

Total assets

 

$

748,027

 

 

 

$

803,990

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

Current liabilities

 

 

 

 

Accounts payable

 

$

3,738

 

 

 

$

5,998

 

 

Accrued expenses

 

28,351

 

 

 

22,982

 

 

Customer deposits

 

83,015

 

 

 

83,211

 

 

Other current liabilities

 

2,981

 

 

 

2,830

 

 

Total current liabilities

 

118,085

 

 

 

115,021

 

 

Non-current liabilities

 

 

 

 

Warrant liability

 

184,159

 

 

 

135,440

 

 

Other long-term liabilities

 

25,939

 

 

 

26,451

 

 

Total liabilities

 

$

328,183

 

 

 

$

276,912

 

 

Stockholders’ Equity

 

 

 

 

Preferred stock, $0.0001 par value; 10,000,000 authorized; none issued and outstanding

 

$

 

 

 

$

 

 

Common stock, $0.0001 par value; 700,000,000 shares authorized; 237,274,430 and 236,123,659 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively

 

23

 

 

 

23

 

 

Additional paid-in capital

 

1,311,607

 

 

 

1,297,794

 

 

Accumulated deficit

 

(891,817

)

 

 

(770,744

)

 

Accumulated other comprehensive income

 

31

 

 

 

5

 

 

Total stockholders’ equity

 

419,844

 

 

 

527,078

 

 

Total liabilities and stockholders’ equity

 

$

748,027

 

 

 

$

803,990

 

 

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited and in thousands)

 

 

 

Three Months Ended

 

 

March 31, 2021

 

March 31, 2020

 

 

 

 

(As restated)

Cash flows from operating activities

 

 

 

 

Net loss

 

$

(129,694

)

 

 

$

(376,826

)

 

Stock-based compensation

 

22,111

 

 

 

4,425

 

 

Depreciation and amortization

 

2,869

 

 

 

2,105

 

 

Change in fair value of warrant liability

 

48,719

 

 

 

316,896

 

 

Other operating activities, net

 

10

 

 

 

1

 

 

Change in assets and liabilities

 

 

 

 

Inventories

 

296

 

 

 

(1,980

)

 

Other current and non-current assets

 

3,692

 

 

 

2,142

 

 

Accounts payable and accrued expenses

 

3,322

 

 

 

(2,978

)

 

Customer deposits

 

(196

)

 

 

(98

)

 

Other current and non-current liabilities

 

102

 

 

 

 

 

Net cash used in operating activities

 

(48,769

)

 

 

(56,313

)

 

Cash flows from investing activity

 

 

 

 

Capital expenditures

 

(819

)

 

 

(4,036

)

 

Cash used in investing activity

 

(819

)

 

 

(4,036

)

 

Cash flows from financing activities

 

 

 

 

Payments of finance lease obligations

 

(34

)

 

 

(23

)

 

Proceeds from issuance of common stock pursuant to stock options exercised

 

10,837

 

 

 

 

 

Transaction costs

 

 

 

 

(697

)

 

Withholding taxes paid on behalf of employees on net settled stock-based awards

 

(10,514

)

 

 

 

 

Net cash provided by (used in) by financing activities

 

289

 

 

 

(720

)

 

Net decrease in cash and cash equivalents

 

(49,299

)

 

 

(61,069

)

 

Cash, cash equivalents and restricted cash at beginning of period

 

678,955

 

 

 

492,721

 

 

Cash, cash equivalents and restricted cash at end of period

 

$

629,656

 

 

 

$

431,652

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

616,625

 

 

 

$

419,374

 

 

Restricted cash

 

13,031

 

 

 

12,278

 

 

Cash, cash equivalents and restricted cash

 

$

629,656

 

 

 

$

431,652

 

 

Use of Non-GAAP Financial Measures (Unaudited)

This press release references certain non-GAAP financial measures, including adjusted EBITDA, non-GAAP selling, general, and administrative expense and non-GAAP research and development expense. The Company defines adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. It defines non-GAAP selling, general, and administrative expenses as selling, general, and administrative expenses other than stock-based compensation and non-capitalized transaction costs, and non-GAAP research and development expenses as research and development expenses other than stock-based compensation. None of these non-GAAP financial measures is a substitute for or superior to measures of financial performance prepared in accordance with generally accepted accounting principles in the United States (GAAP) and should not be considered as an alternative to any other performance measures derived in accordance with GAAP.

The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.

A reconciliation of adjusted EBITDA to net loss for the three months ended March 31, 2021 and March 31, 2020 , respectively, are set forth below:

Amounts in thousands ($)

 

Three Months Ended

 

 

March 31, 2021

 

March 31, 2020

Net Loss

 

(129,694

)

 

(376,826

)

Income tax benefit (expense)

 

(43

)

 

46

 

Interest expense

 

7

 

 

9

 

Depreciation & amortization

 

2,869

 

 

2,105

 

Non-capitalized transaction costs*

 

 

 

697

 

Stock-based compensation

 

22,111

 

 

4,425

 

Change in fair value of warrants

 

48,719

 

 

316,896

 

Adjusted EBITDA

 

(55,945

)

 

(52,740

)

A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three months ended March 31, 2021 and March 31, 2020, respectively, are set forth below:

Amounts in thousands ($)

 

Three Months Ended

 

 

March 31, 2021

 

March 31, 2020

Selling, general, and administrative expenses

 

44,914

 

 

26,755

 

Stock-based compensation

 

18,038

 

 

2,870

 

Non-capitalized transaction costs*

 

 

 

697

 

Non-GAAP selling, general, administration expenses

 

$

26,876

 

 

$

23,188

 

 

A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended March 31, 2021 and March 31, 2020, respectively, are set forth below:

Amounts in thousands ($)

 

Three Months Ended

 

 

March 31, 2021

 

March 31, 2020

Research and development expenses

 

36,363

 

 

34,282

 

Stock-based compensation

 

4,074

 

 

1,555

 

Non-GAAP Research and development expenses

 

$

32,289

 

 

$

32,727

 

_____________

Non-capitalized transaction costs include non-recurring expenses related to preparation and filing of an S-1 registration statement in the first quarter of 2020.

 

Contacts

For investor relations inquiries:
Seth Zaslow – Vice President, Investor Relations

seth.zaslow@virgingalactic.com

For media inquiries:
Aleanna Crane – Vice President, Communications

aleanna.crane@virgingalactic.com

0 comments